Latest News Releases From The Newsroom
Quarterly Results Ahead: Adobe, Kroger, Jabil, and Cognyte Reports Coming
June 10th, 2023
Thursday, June 15, will see several companies releasing their financial results, including: Adobe Inc. (Nasdaq: ADBE), a global leader in digital media and marketing solutions, is set to announce its second-quarter fiscal year 2023 results after t. Read more
Earnings Figures Preview: Lennar, Anterix, Aurora Cannabis, and High Tide
June 10th, 2023
Several companies are expected to report their financial results on Wednesday, June 14, including: Lennar Corporation (NYSE: LEN)(NYSE:LEN.B), a leading home construction and real estate development company, is set to announce its second-qua. Read more
Biogen: FDA Panel Backs OK of Alzheimer's Drug; Disc Medicine: Upgraded, Promising Trial Data
June 10th, 2023
Eisai and Biogen's (Nasdaq: BIIB) Alzheimer's drug candidate, LEQEMBI (lecanemab-irmb), received unanimous support from FDA PCNS panel based on Phase 3 Clarity AD trial data. The committee acknowledged its clinical benefit, overall benefit-r. Read more
GE Awarded up to $422.81M Contract; Primerica, CRISPR, Cineverse and Corning: PT Hiked
June 10th, 2023
General Electric Company's (NYSE: GE) subsidiary, GE Aerospace, has secured a significant contract from the Defense Logistics Agency Aviation for supplies related to the F-series engines (F101/110/118). The firm-fixed price, requirements-typ. Read more
23andMe: Strategic Move; Oracle, Tesla and Microsoft: PT Boost Hint at Potential Upsides
June 09th, 2023
23andMe Holding Co. (Nasdaq: ME), a leading genetic testing and personal genomics company, has disclosed in a regulatory filing with the SEC a reduction in force involving around 75 employees, representing approximately 9% of its workforce. . Read more
Pfizer to End License Deal with Theravance Bio; Truist Bullish On Vail Resorts and Leonardo DRS
June 09th, 2023
Theravance Biopharma Ireland Limited, an affiliate of Theravance Biopharma, Inc. (Nasdaq: TBPH), entered into a global license agreement with Pfizer Inc. (NYSE: PFE) in December 2019 for its preclinical skin-selective, locally acting pan-JAK inhibito. Read more
Aehr Test Systems Gets $13.7M in Orders; Fisker Targets Chinese Market
June 09th, 2023
Aehr Test Systems (Nasdaq: AEHR) has secured significant orders worth $13.7 million from a leading Fortune 500 semiconductor device supplier, who is a major player in the automotive semiconductor market. The orders are for Aehr's WaferPak fu. Read more
Vertex Pharma, CRISPR Surge On Exa-cel Trials Data; Sonoma Pharma Soars on Pulse Lavage Irrigation Solution
June 09th, 2023
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics AG (Nasdaq: CRSP) have announced positive results from pivotal trials for their investigational treatment, exagamglogene autotemcel (exa-cel), in patients with transfusion-dep. Read more
Canaccord Bullish on Joby Aviation, Lilium, Vertical Aerospace, Eve, Archer Aviation: eVTOL Stocks
June 09th, 2023
Joby Aviation, Inc. (NYSE: JOBY), a leading electric aviation company focused on the development of vertical takeoff and landing (VTOL) aircraft, has been initiated with a Buy rating and Price Target of $8 by Canaccord Genuity. With $JOBY cl. Read more
Braze, Duckhorn, General Motors, and Tesla: Earnings, Guidance, and Collaboration Updates
June 09th, 2023
Braze, Inc. (Nasdaq: BRZE) reported a first-quarter fiscal 2024 loss of $0.13 per share, better than the consensus estimate of a loss of $0.18 per share. The company has also provided guidance for the second quarter, expecting an adjusted lo. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Countdown to Earnings: Nutanix, CrowdStrike, and Synopsys on Deck
August 23rd, 2026Investors Eye Semtech, Intuit, and nCino as Earnings Loom
August 22nd, 2026FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
August 21st, 2026
Member Login